EB
Publications
233
Views
97 814
Downloads
18 489
Supervised works
0
Items per page
1 - 233 of 233
Title Published in Access level OA Policy Year Views Downloads
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV) : a multicenter, international, non-randomized clinical trial study protocolBMC infectious diseases
accessLevelPublic
2024 15 5
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIVClinical pharmacology and therapeutics
accessLevelPublic
2024 4 1
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3)The journal of infectious diseases
accessLevelPublic
2024 27 2
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral TherapyClinical infectious diseases
accessLevelPublic
2023 43 13
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV) : A Study Combining Modelling and Swiss HIV Cohort DataClinical infectious diseases
accessLevelPublic
2023 61 11
Viral suppression and retention in HIV care during the postpartum period among women living with HIV : a longitudinal multicenter cohort studyThe Lancet regional health. Europe
accessLevelPublic
2023 13 2
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimenBritish journal of clinical pharmacology
accessLevelPublic
2023 57 12
External validation of the Dat'AIDS score : A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or olderHIV medicine
accessLevelPublic
2023 54 7
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV CoinfectionClinical infectious diseases
accessLevelRestricted
2023 76 0
Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohortHIV medicine
accessLevelPublic
2023 51 13
Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort studyAIDS
accessLevelPublic
2023 62 8
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV : The Swiss HIV Cohort StudyThe Journal of infectious diseases
accessLevelPublic
2023 43 10
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 13 5
Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus (HIV) in SwitzerlandClinical infectious diseases
accessLevelPublic
2023 45 7
Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 comparedThe journal of infectious diseases
accessLevelPublic
2023 49 20
Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort StudyClinical infectious diseases
accessLevelPublic
2023 54 12
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 10 7
Sexual Behaviour and STI Incidence in Sexually Active MSM Living With HIV in Times of COVID-19Open forum infectious diseases
accessLevelPublic
2023 51 9
Legionnaires' disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO)Infection
accessLevelPublic
2023 35 8
A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease TraitsMolecular biology and evolution
accessLevelPublic
2022 102 42
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 EpidemicsJournal of acquired immune deficiency syndromes
accessLevelPublic
2022 111 20
An Approach to Quantifying the Interaction between Behavioral and Transmission ClustersViruses
accessLevelPublic
2022 48 6
LOw-dose CT Or Lung UltraSonography versus standard of care based-strategies for the diagnosis of pneumonia in the elderly: protocol for a multicentre randomised controlled trial (OCTOPLUS)BMJ open
accessLevelPublic
2022 90 55
Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional StudyJournal of immigrant and minority health
accessLevelPublic
2022 43 21
Transfer of antiretroviral drugs into breastmilk : a prospective study from the Swiss Mother and Child HIV Cohort StudyJournal of antimicrobial chemotherapy
accessLevelPublic
2022 38 10
A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort StudyThe journal of infectious diseases
accessLevelRestricted
2022 56 0
Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitalsLancet. Infectious diseases
accessLevelPublic
2022 141 172
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort studyThe journal of antimicrobial chemotherapy
accessLevelRestricted
2022 50 0
Anticholinergic and sedative medications are associated with neurocognitive performance of well treated people with human immunodeficiency virusOpen forum infectious diseases
accessLevelPublic
2022 28 11
A highly virulent variant of HIV-1 circulating in the NetherlandsScience
accessLevelPublic
2022 124 15
Risk Factors and Incidence of Sexually Transmitted Infections in the Swiss HIV Cohort StudyOpen forum infectious diseases
accessLevelPublic
2022 77 33
Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)HIV medicine
accessLevelPublic
2022 57 9
Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmissionHIV Medicine
accessLevelRestricted
2021 187 0
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort StudyOpen Forum Infectious Diseases
accessLevelPublic
2021 211 85
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape linkeLife
accessLevelPublic
2021 118 44
The role of Human Immunodeficiency Virus (HIV) asymptomatic status when starting antiretroviral therapy on adherence and treatment outcomes and implications for test and treat: the swiss HIV Cohort StudyClinical Infectious Diseases
accessLevelRestricted
2021 115 0
Identifying and characterizing trans women in the swiss HIV Cohort Study as an epidemiologically distinct risk groupClinical Infectious Diseases
accessLevelRestricted
2021 121 0
Increasing Frequency and Transmission of HIV-1 Non-B Subtypes among Men Who Have Sex with Men in the Swiss HIV Cohort StudyThe Journal of Infectious Diseases
accessLevelRestricted
2021 112 0
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized TrialEClinicalMedicine
accessLevelPublic
2021 561 95
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort StudyAnnals of internal medicine
accessLevelRestricted
2021 125 0
Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study : 1980-2018Antiviral therapy
accessLevelRestricted
2020 26 0
HCV genetic diversity can be used to infer infection recency and time since infectionViruses
accessLevelPublic
2020 151 51
Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatmentJournal of Acquired Immune Deficiency Syndromes
accessLevelRestricted
2020 175 0
Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIVPLoS biology
accessLevelPublic
2020 47 8
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trialPLOS Medicine
accessLevelPublic
2020 140 88
Repeated syphilis episodes in HIV-infected men who have sex with men: a multicenter prospective cohort study on risk factors and the potential role of syphilis immunityOpen Forum Infectious Diseases
accessLevelPublic
2020 237 86
Phylogenetic cluster analysis identifies virological and behavioral drivers of HIV transmission in MSMClinical Infectious Diseases
accessLevelRestricted
2020 331 12
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?HIV medicine
accessLevelPublic
2020 56 9
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ARTNature Communications
accessLevelPublic
2020 176 37
Contribution of Genetic Background and Data Collection on Adverse Events of Anti–human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration RateClinical Infectious Diseases
accessLevelRestricted
2020 223 0
Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patientsClinical Infectious Diseases
accessLevelRestricted
2020 273 3
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ARTNature Communications
accessLevelPublic
2019 246 93
Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patientsOpen Forum Infectious Diseases
accessLevelPublic
2019 249 190
HIV Transmission Chains Exhibit Greater HLA-B Homogeneity Than Randomly ExpectedJournal of Acquired Immune Deficiency Syndromes
accessLevelRestricted
2019 236 0
Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherenceThe journal of antimicrobial chemotherapy
accessLevelRestricted
2019 43 0
Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up eraThe Journal of Infectious Diseases
accessLevelPublic
2019 736 202
Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk predictionInternational Journal of Cancer
accessLevelPublic
2019 255 110
A systematic phylogenetic approach to study the interaction of HIV-1 with coinfections, noncommunicable diseases, and opportunistic diseasesThe Journal of Infectious Diseases
accessLevelRestricted
2019 262 0
Why do sub‐Saharan Africans present late for HIV care in Switzerland ?HIV medicine
accessLevelRestricted
2019 40 0
Viral diversity based on next-generation sequencing of HIV-1 provides precise estimates of infection recency and time since infectionThe Journal of Infectious Diseases
accessLevelRestricted
2019 221 0
On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling studyJournal of viral hepatitis
accessLevelPublic
2018 1 650 420
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort StudyLiver International
accessLevelRestricted
2018 413 0
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort StudyVirus Evolution
accessLevelPublic
2018 283 64
Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID StudyKidney International Reports
accessLevelPublic
2018 401 141
The cumulative impact of harm reduction on the swiss HIV epidemic: cohort study, mathematical model, and phylogenetic analysisOpen Forum Infectious Diseases
accessLevelPublic
2018 268 76
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite PathogenicityMolecular Biology and Evolution
accessLevelPublic
2018 430 159
Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?Swiss Medical Weekly
accessLevelRestricted
2018 374 0
Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in SwitzerlandHIV Medicine
accessLevelRestricted
2018 495 0
Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS)BMJ Open
accessLevelPublic
2018 506 217
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activityThe Journal of experimental medicine
accessLevelPublic
2018 259 91
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretroviralsMedicine (Philadelphia)
accessLevelPublic
2017 352 154
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general populationAIDS
accessLevelPublic
2017 356 145
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysiseLife
accessLevelPublic
2017 438 162
Hepatitis delta-associated mortality in HIV/HBV-coinfected patientsJournal of Hepatology
accessLevelPublic
2017 347 294
Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort StudyHIV Medicine
accessLevelRestricted
2017 336 0
High prevalence of physical inactivity among patients from the Swiss HIV Cohort StudyAIDS Care
accessLevelPublic
2017 336 310
Human papillomavirus antibody response following HAART initiation among MSMAIDS
accessLevelRestricted
2017 371 0
Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort StudyClinical Infectious Diseases
accessLevelRestricted
2017 329 0
Adverse events of raltegravir and dolutegravirAIDS
accessLevelPublic
2017 363 140
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort studyBMC Infectious Diseases
accessLevelPublic
2017 367 154
Mining for pairs: shared clinic visit dates identify steady HIV-positive partnershipsHIV Medicine
accessLevelRestricted
2017 388 0
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialThe Lancet Infectious Diseases
accessLevelRestricted
2017 506 0
Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland comparedInternational journal of infectious diseases
accessLevelPublic
2016 451 129
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventionsHepatology
accessLevelPublic
2016 641 214
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in SwitzerlandScientific Reports
accessLevelPublic
2016 1 015 250
Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort StudyOpen Forum Infectious Diseases
accessLevelPublic
2016 428 230
Determinants of HIV-1 broadly neutralizing antibody inductionNature Medicine
accessLevelPublic
2016 484 384
Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort StudyThe Journal of Infectious Diseases
accessLevelPublic
2016 371 186
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort studyInternational journal of cancer
accessLevelPublic
2016 583 225
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort AnalysisClinical Infectious Diseases
accessLevelRestricted
2016 613 1
HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort StudyClinical Infectious Diseases
accessLevelPublic
2016 449 140
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational periodHIV medicine
accessLevelRestricted
2016 437 0
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in SwitzerlandAIDS
accessLevelRestricted
2015 46 0
Reasons for late presentation to HIV care in SwitzerlandJournal of the International AIDS Society
accessLevelPublic
2015 38 3
Syphilis: Diagnostik und BehandlungSwiss Medical Forum
accessLevelPublic
2015 285 467
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012The Journal of infectious diseases
accessLevelRestricted
2015 534 0
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General PopulationOpen forum infectious diseases
accessLevelPublic
2015 519 214
Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disordersAIDS research and therapy
accessLevelPublic
2015 559 283
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort StudyJournal of Antimicrobial Chemotherapy
accessLevelPublic
2015 393 154
Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCVInternational journal of epidemiology
accessLevelPublic
2014 665 409
Disentangling human tolerance and resistance against HIVPLoS biology
accessLevelPublic
2014 577 309
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patientsAIDS
accessLevelRestricted
2014 468 0
AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to beJournal of the International AIDS Society
accessLevelPublic
2014 554 239
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patientsAIDS
accessLevelRestricted
2014 516 0
Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort StudyClinical infectious diseases
accessLevelRestricted
2014 641 0
Social Meets Molecular: Combining Phylogenetic and Latent Class Analyses to Understand HIV-1 Transmission in SwitzerlandAmerican journal of epidemiology
accessLevelPublic
2014 779 24
Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wideThe Journal of infectious diseases
accessLevelRestricted
2014 521 0
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort StudyOpen forum infectious diseases
accessLevelPublic
2014 913 328
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infectionThe Journal of infectious diseases
accessLevelRestricted
2013 588 0
High proportion of healthcare-associated urinary tract infection in the absence of prior exposure to urinary catheter: a cross-sectional studyAntimicrobial resistance and infection control
accessLevelPublic
2013 630 1 413
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2013 567 0
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patientsPLoS computational biology
accessLevelPublic
2013 619 222
HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosisPLOS genetics
accessLevelPublic
2013 856 596
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individualsPharmacogenetics and genomics
accessLevelRestricted
2013 553 0
Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort StudyPloS one
accessLevelPublic
2013 539 539
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)Journal of acquired immune deficiency syndromes
accessLevelRestricted
2013 529 0
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral controleLife
accessLevelPublic
2013 586 222
Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2013 505 0
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort StudyAntiviral therapy
2013 680 0
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort studyThe Journal of infectious diseases
accessLevelRestricted
2013 584 0
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infectionBritish journal of cancer
accessLevelPublic
2012 504 1 041
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavirAIDS
accessLevelRestricted
2012 567 0
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimensPloS one
accessLevelPublic
2012 579 250
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physiciansHIV medicine
accessLevelRestricted
2012 538 0
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemicClinical infectious diseases
accessLevelRestricted
2012 500 0
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinationsClinical infectious diseases
accessLevelPublic
2012 994 238
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2012 562 0
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2012 542 1
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patientsPloS one
accessLevelPublic
2012 583 214
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomesPloS one
accessLevelPublic
2012 557 438
Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype BClinical infectious diseases
accessLevelPublic
2011 538 368
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infectionClinical infectious diseases
accessLevelPublic
2011 830 720
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2011 558 0
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients : The ACHIEV2E Collaboration Study GroupClinical infectious diseases
accessLevelRestricted
2011 52 0
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals: the Swiss HIV Cohort StudyJournal of translational medicine
accessLevelPublic
2011 610 279
Overall burden of healthcare-associated infections among surgical patients. Results of a national studyAnnals of surgery
accessLevelRestricted
2011 536 0
The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in SwitzerlandThe Journal of infectious diseases
accessLevelPublic
2011 613 583